Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Learn about the flu shot, COVID-19 vaccine, and our masking policy »
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Get the iPhone MyHealth app »
Get the Android MyHealth app »
SEPTICEMIC LOW-BIRTH-WEIGHT NEONATES TREATED WITH HUMAN-ANTIBODIES TO ENDOTOXIN ARCHIVES OF DISEASE IN CHILDHOOD Adhikari, M., Coovadia, H. M., Gaffin, S. L., BROCKUTNE, J. G., MARIVATE, M., Pudifin, D. J. 1985; 60 (4): 382-384
Abstract
In a double blind controlled study antilipopolysaccharide gammaglobulin given intramuscularly did not reduce mortality in low birthweight babies suffering from septicaemia. It did, however, reduce the recovery period of survivors from 310 to 120 hours.
View details for Web of Science ID A1985AGV4900024
View details for PubMedID 3890768